Prognostic value of the dual-tracer PET score (NETPET) in neuroendocrine tumors with [225Ac]Ac-DOTATATE therapy

Ya Liu, Tingting Xu, Hongyu Yang, Zhanwen Huang, Haoyuan Ding, Yu Zhang, Yue Chen

Open source

DOI
10.1007/s00259-026-08138-0
Published
2026-08-17
Container
European Journal of Nuclear Medicine and Molecular Imaging
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00259-026-08138-0,
  title = {Prognostic value of the dual-tracer PET score (NETPET) in neuroendocrine tumors with [225Ac]Ac-DOTATATE therapy},
  author = {Ya Liu and Tingting Xu and Hongyu Yang and Zhanwen Huang and Haoyuan Ding and Yu Zhang and Yue Chen},
  year = {2026},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  doi = {10.1007/s00259-026-08138-0},
  url = {https://doi.org/10.1007/s00259-026-08138-0}
}

RIS

TY  - JOUR
TI  - Prognostic value of the dual-tracer PET score (NETPET) in neuroendocrine tumors with [225Ac]Ac-DOTATATE therapy
AU  - Ya Liu
AU  - Tingting Xu
AU  - Hongyu Yang
AU  - Zhanwen Huang
AU  - Haoyuan Ding
AU  - Yu Zhang
AU  - Yue Chen
PY  - 2026
JO  - European Journal of Nuclear Medicine and Molecular Imaging
DO  - 10.1007/s00259-026-08138-0
UR  - https://doi.org/10.1007/s00259-026-08138-0
ER  - 

APA

Liu, Y., Xu, T., Yang, H., Huang, Z., Ding, H., Zhang, Y., & Chen, Y. (2026). Prognostic value of the dual-tracer PET score (NETPET) in neuroendocrine tumors with [225Ac]Ac-DOTATATE therapy. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08138-0

Source records